Sio Capital Management LLC Sells 253,333 Shares of CVS Health Corp (NYSE:CVS)

Sio Capital Management LLC lessened its position in CVS Health Corp (NYSE:CVS) by 69.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 113,738 shares of the pharmacy operator’s stock after selling 253,333 shares during the quarter. CVS Health accounts for approximately 1.5% of Sio Capital Management LLC’s portfolio, making the stock its 20th largest holding. Sio Capital Management LLC’s holdings in CVS Health were worth $6,198,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Capital Investment Advisory Services LLC boosted its holdings in shares of CVS Health by 3.8% during the first quarter. Capital Investment Advisory Services LLC now owns 5,128 shares of the pharmacy operator’s stock worth $277,000 after purchasing an additional 189 shares during the period. Fiduciary Group LLC boosted its holdings in shares of CVS Health by 3.2% during the second quarter. Fiduciary Group LLC now owns 6,485 shares of the pharmacy operator’s stock worth $353,000 after purchasing an additional 200 shares during the period. First Command Financial Services Inc. boosted its holdings in shares of CVS Health by 16.0% during the second quarter. First Command Financial Services Inc. now owns 1,464 shares of the pharmacy operator’s stock worth $80,000 after purchasing an additional 202 shares during the period. Hudock Capital Group LLC boosted its holdings in shares of CVS Health by 54.0% during the second quarter. Hudock Capital Group LLC now owns 576 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 202 shares during the period. Finally, Rikoon Group LLC boosted its holdings in shares of CVS Health by 1.9% during the second quarter. Rikoon Group LLC now owns 10,743 shares of the pharmacy operator’s stock worth $585,000 after purchasing an additional 204 shares during the period. 75.89% of the stock is currently owned by hedge funds and other institutional investors.

In other news, CFO Eva C. Boratto sold 8,130 shares of CVS Health stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $65.00, for a total transaction of $528,450.00. Following the completion of the transaction, the chief financial officer now directly owns 55,273 shares in the company, valued at $3,592,745. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is currently owned by company insiders.



A number of research firms have recently weighed in on CVS. Bank of America increased their target price on shares of CVS Health from $72.00 to $75.00 and gave the stock a “buy” rating in a report on Thursday, September 12th. Standpoint Research upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Wednesday, June 5th. TheStreet upgraded shares of CVS Health from a “c+” rating to a “b-” rating in a report on Monday, September 9th. Deutsche Bank began coverage on shares of CVS Health in a report on Thursday, September 12th. They set a “buy” rating and a $91.00 target price for the company. Finally, Morgan Stanley reiterated a “buy” rating and set a $74.00 target price on shares of CVS Health in a report on Sunday, August 11th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. CVS Health presently has an average rating of “Buy” and an average price target of $75.91.

CVS traded down $0.46 on Wednesday, hitting $63.02. The company had a trading volume of 164,498 shares, compared to its average volume of 7,257,627. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.95 and a quick ratio of 0.64. CVS Health Corp has a 52-week low of $51.72 and a 52-week high of $82.15. The stock has a fifty day simple moving average of $60.08 and a 200-day simple moving average of $55.92. The firm has a market capitalization of $83.31 billion, a P/E ratio of 8.91, a P/E/G ratio of 1.40 and a beta of 0.85.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.70 by $0.19. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The firm had revenue of $63.43 billion during the quarter, compared to analyst estimates of $62.66 billion. During the same period last year, the business earned $1.69 earnings per share. The business’s revenue was up 35.2% on a year-over-year basis. Equities research analysts expect that CVS Health Corp will post 6.96 earnings per share for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: What does a bar chart display?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.